Adaptimmune is a leader in TCR T-cell therapy, focused on designing and delivering novel cancer immunotherapy products. We utilize the body's own machinery ...
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.
People also ask
Should I buy ADAP stock?
How big is Adaptimmune company?
What is the revenue of Adaptimmune?
Where is Adaptimmune located?
... investing for the long-haul, we have you covered. Delivered Mondays. All Text Fields Are Required. Thanks for submitting! Investor Relations · Contact · Careers ...
Find the latest SEC Filings data for Adaptimmune Therapeutics plc American Depositary Shares (ADAP) including 10-K and 10-Q forms at Nasdaq.com.
Investor Relations · Estimates · Industry · Modeling · Dividends · Ownership · Filings · Charting · Screener. Investors. Investor Holdings · Super Investors.
3 days ago · Find the latest Adaptimmune Therapeutics plc (ADAP) stock quote, history, news and other vital information to help you with your stock ...
$ADAP aims to redefine cancer treatment in solid tumors with cell therapy. For meetings with management email: investor.relations@adaptimmune.com.